TG Therapeutics Licenses Maxcyte Tech to Develop Cell Therapies for Autoimmune Disease
To support the development and commercialization of a novel immunotherapy, biopharmaceutical company TG Therapeutics has signed a deal to license MaxCyte’s Flow Electroporation® technology and ExPERT platform.
Under the terms of the agreement, the company...
Beyond Genetics: The Impact of Environmental Factors on Biological Processes
The realm of genetics has witnessed remarkable advancements over the past two decades since the completion of the Human Genome Project. This monumental endeavor not only sequenced the entirety of a human genome but...
What’s in a Name: Out with Invizyne, In with eXoZymes
eXoZymes CEO Michael Heltzen
Publicly traded Invizyne Technologies is renaming itself eXoZymes, a rebranding intended to raise the company’s profile by highlighting the sustainable, cell-free enzyme technology its co-founders and colleagues have spent more than...
Insilico Medicine announces preclinical drug discovery benchmarks from 2021 to 2024
Insilico Medicine ( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks from the 22 developmental candidate nominations achieved by its platform from...
Insilico Medicine Unveils Key Developmental Milestones and Timelines for Novel AI-Driven Therapeutics
In an era where biotechnology is rapidly evolving through the integration of artificial intelligence (AI), Insilico Medicine has emerged as a groundbreaking player in the field of drug discovery. Based in Cambridge, Massachusetts, this...
Yale rewrites genetic code for new proteins
Synthetic biologists from Yale were able to re-write the genetic code of an organism - a novel genomically recoded organism (GRO) with one stop codon - using a cellular platform that they developed enabling...
Imminent Breakthroughs in Fully Autonomous AI Technology
Researchers are on the verge of a significant breakthrough in artificial intelligence with the development of a novel algorithm named Torque Clustering. This innovative approach represents a substantial leap toward achieving a form of...
Intra-ImmuSG Focuses on Intracellular Targets for Cancer Immunotherapy
Cancer immunotherapy seeks to harness the natural protective ability of our immune system to fight against cancer. A market report published by Grand View Research estimated that the global cancer immunotherapy market size is...
AGBT Debrief: What’s Happening in NGS and Multiomics?
Register NowPanelists:Catharine AquinoGroup LeaderGenomics AnalyticsFunctional Genomics Center Zurich, ETH ZurichCharlie Johnson, PhDDirectorGenomics and Bioinformatics ServicesTexas A&M AgriLife ResearchJasmine Plummer, PhDFounding DirectorCenter for Spatial OmicsSt. Jude Children’s HospitalJessica Nordlund, PhDAssociate Professor and Research Group LeaderUppsala...
Study examines how diet impacts gene expression in fat tissue
As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC. New research from the University of...















